Arioneo, a French company which specializes in the development and marketing of analysis solutions for the performance and health of equine athletes, has created a new study aimed at the deployment of a new generation of automated ECG-analysis algorithms capable of detecting cardiac rhythm abnormalities, including atrial fibrillation (AFib), across training, racing and resting conditions.
In a press release Tuesday, the company states that the study is “powered by an artificial intelligence engine trained on one of the largest exercise ECG datasets in the racing industry, [which] enables, for the first time, large-scale cardiac screening in racehorses under real-world conditions.”
“Exercise-related cardiac events remain underdiagnosed,” said Dr Guillaume Dubois, Scientific Director, Arioneo/LIM Group. “Automation now makes systematic screening feasible at scale, improving both horse welfare and race safety.”
The release also mentions new equipment in the works, stating, “Arioneo is also finalising a new ultra-thin race-day girth integrating ECG electrodes and locomotion sensors that sits under the saddle cloth. This solution enables seamless cardiac and stride patterns monitoring without additional equipment, opening the door to pre-race screening protocols.”.
Arioneo is opening pilot programs in 2026 with racing authorities, racetracks and regulatory bodies.
Not a subscriber? Click here to sign up for the daily PDF or alerts.
